SCHEMBL4364281

SCHEMBL4364281

CC(C)(Cc1ccc(F)cc1)N(C(=O)c1ccc(-c2ccc(O)cc2)cc1)[C@@H](CCC(=O)O)C(N)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 2/20 0.46
MMP2 P08253 1/20 0.46
MMP8 P22894 1/20 0.46
ADAMTS5 Q9UNA0 1/20 0.46
MCHR1 Q99705 1/20 0.35
BLM P54132 1/20 0.35
S1PR1 P21453 1/20 0.35
MME P08473 1/20 0.33
TAS2R14 Q9NYV8 1/20 0.33
LTB4R2 Q9NPC1 2/20 0.33
FOLH1 Q04609 3/20 0.32
ESRRG P62508 1/20 0.32
ROCK1 Q13464 1/20 0.32
HSP90AA1 P07900 1/20 0.32
HSP90AB1 P08238 1/20 0.32
PDK1 Q15118 1/20 0.32
PDK2 Q15119 1/20 0.32
PDK3 Q15120 1/20 0.32
PDK4 Q16654 1/20 0.32
TPH1 P17752 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2249890 0.96 MMP12 (0.48) MMP12MMP2MMP8ADAMTS5MCHR1
SCHEMBL2242485 0.91 MMP2 (0.45) MMP12MMP2MMP8ADAMTS5MCHR1
SCHEMBL2248769 0.90 MMP12 (0.44) MMP12MMP2MMP8ADAMTS5MCHR1
SCHEMBL2254232 0.89 MMP12 (0.47) MMP12MMP2MMP8ADAMTS5MME
SCHEMBL2247913 0.88 MMP2 (0.39) MMP12MMP2MMP8ADAMTS5MCHR1
SCHEMBL2251633 0.88 MMP2 (0.41) MMP12MMP2MMP8ADAMTS5FOLH1
SCHEMBL2247591 0.88 MMP12 (0.42) MMP12MMP2MMP8ADAMTS5MCHR1
SCHEMBL2248055 0.87 MMP2 (0.42) MMP12MMP2MMP8ADAMTS5MCHR1
SCHEMBL2247681 0.86 MMP12 (0.45) MMP12MMP2MMP8ADAMTS5MME
SCHEMBL2247710 0.86 ADAMTS5 (0.38) MMP12MMP2MMP8ADAMTS5MCHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7553873-B2 Glutamate aggrecanase inhibitors WYETH (US) 2009-06-30 US disclosed
US-20070043066-A1 Glutamate aggrecanase inhibitors WYETH (US) 2007-02-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043066-A1 Glutamate aggrecanase inhibitors ADAMTS5, ADAMTS1, ADAMTS7 MMP12 54/4885MMP2 49/4885MMP8 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.